Adam Gorlitsky to Receive ReWalk Personal Exoskeleton System on 10th Anniversary of Accident that Left Him Paralyzed
ReWalk to Deliver System to Roper Rehabilitation Hospital in Charleston
YOKNEAM ILIT, Israel and MARLBOROUGH, MA– ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk”), the leading global exoskeleton developer and manufacturer, will deliver a Personal Exoskeleton system to Adam Gorlitsky at the Roper Rehabilitation Hospital in Charleston, SC on Wednesday, Dec. 30.
ReWalk will deliver the system to Adam on the 10th anniversary of the car accident that caused his spinal cord injury. The media is invited to watch Adam demonstrate his system and interview him, along with representatives from Roper Rehabilitation Hospital and ReWalk Robotics.
“We are so pleased to deliver a ReWalk system to Adam this week, and have him join the ranks of ReWalkers around the world,” said ReWalk Robotics CEO Larry Jasinski. “We are proud to work with dozens of rehabilitation hospitals across the country like Roper Rehabilitation Hospital, which help expose the spinal cord injured community to this technology, and provide training so that eligible ReWalkers can have the chance to stand and walk again.”
This historic event is a testament to the quality of cutting-edge technology offered at Roper Rehabilitation Hospital, the only CARF-accredited spinal cord injury program in the Lowcountry, said Cathy Therrell, director of Roper Rehabilitation Hospital. “We are so proud of Adam and we are thrilled to be the first to offer ReWalk to persons with spinal cord injuries in South Carolina,” Therrell said.
Adam, 29, fell asleep while driving December 30, 2005, which led to a car accident that severed his spinal cord at the T9 level, permanently paralyzing him from the waist down. In 2015, Adam was introduced to the ReWalk exoskeleton at Roper Rehabilitation Hospital, located inside Roper Hospital in downtown Charleston. Over the course of five months, he has nearly completed his training on the ReWalk and will finalize his training with his own personal system. Adam led a successful crowdfunding campaign on his website I Got Legs, which will pay for his ReWalk system. Once his training is complete, Adam will be able to use the ReWalk to stand, walk and return to many activities he once did every day.
“For the past 10 years, I have been forced to accept the challenges and limitations that my injury would bring me,” Adam said. “This has touched not only my life, but that of my family, friends and loved ones. That’s why the ReWalk Robotics exoskeleton is so important to me and the rest of the spinal cord injury community. Words cannot describe how much I want to hug a girlfriend standing up, or just talk with someone at eye level. With ReWalk, I can do those things — things I never thought I ever would —again.”
Once he has his system home, Adam plans to participate in the Cooper Bridge Run on April 2, 2016 to help raise awareness about exoskeleton technology for people with spinal cord injuries.
ReWalk is a wearable robotic exoskeleton that provides powered hip and knee motion to enable individuals with Spinal Cord Injury (SCI) to stand upright and walk. The system provides user-initiated mobility through the integration of a wearable brace support, a computer-based control system and motion sensors. The system allows independent, controlled walking while mimicking the natural gait patterns of the legs. ReWalk is the only FDA cleared exoskeleton system in the U.S., with clearances for both personal use at home and in the community, as well as for the rehabilitation setting. ReWalk received its FDA clearance for Personal use in 2014, and its Rehabilitation clearance in 2011. ReWalk has also received regulatory clearances for their systems in several global geographies including: North America, Europe, the Middle East and Australia.
About Roper St. Francis:
Roper St. Francis is Charleston’s only private, not-for-profit hospital system with a specific focus on community outreach. The healthcare system has three hospitals strategically located across the region: Roper Hospital on the Charleston peninsula, Bon Secours St. Francis Hospital in West Ashley and Roper St. Francis Mount Pleasant Hospital in Mount Pleasant. The system intends to build a fourth flagship hospital in the Carnes Crossroads section of Berkeley County.
Roper St. Francis is one of the Lowcountry’s largest private employers with nearly 5,600 employees. The healthcare system has a robust, active medical staff of more than 800 doctors representing every medical specialty and provides services in more than 125 locations in seven counties. Learn more at www.rsfh.com.
About ReWalk Personal 6.0
ReWalk Personal 6.0 is a wearable robotic exoskeleton that provides powered hip and knee motion to enable individuals with spinal cord injury to stand upright and walk. The system provides user-initiated mobility through the integration of a wearable brace support, a computer-based control system and motion sensors. The system allows independent, controlled walking while mimicking the natural gait patterns of the legs. The ReWalk device is the most studied exoskeleton in the industry. Studies have identified a number of health benefits including: improved bladder and bowel function, improved mental health, improved sleep, reduced fatigue, decreased body fat, decreased pain and improved posture and balance.
About ReWalk Robotics Ltd.
ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with spinal cord injury. Our mission is to fundamentally change the quality of life for individuals with lower limb disability through the creation and development of market leading robotic technologies. Founded in 2001, ReWalk has headquarters in the US, Israel and Germany. For more information on the ReWalk systems, please visit www.rewalk.com/de.
ReWalk® is a registered trademark of ReWalk Robotics Ltd. in Israel.
Forward Looking Statements
In addition to historical information, this press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the U.S. Securities Act of 1933, and Section 21E of the U.S. Securities Exchange Act of 1934. Such forward-looking statements may include projections regarding ReWalk’s future performance and, in some cases, may be identified by words like “anticipate,” “assume,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “future,” “will,” “seek” and similar terms or phrases. The forward-looking statements contained in this press release are based on management’s current expectations, which are subject to uncertainty, risks and changes in circumstances that are difficult to predict and many of which are outside of ReWalk’s control. Important factors that could cause ReWalk’s actual results to differ materially from those indicated in the forward-looking statements include, among others: ReWalk’s expectations regarding future growth, including its ability to increase sales in its existing geographic markets and to expand to new markets; ReWalk’s ability to maintain and grow its reputation and the market acceptance of our products; ReWalk’s ability to achieve reimbursement from third-party payors for our products; ReWalk’s expectations as to its clinical research program and clinical results; ReWalk’s ability to improve its products and develop new products; ReWalk’s ability to maintain adequate protection of its intellectual property and to avoid violation of the intellectual property rights of others; ReWalk’s ability to gain and maintain regulatory approvals; ReWalk’s ability to maintain relationships with existing customers and develop relationships with new customers; and other factors discussed under the heading “Risk Factors” in ReWalk’s U.S. Annual Report on Form 20-F for the year ended December 31, 2014 filed with the U.S. Securities and Exchange Commission on February 27, 2015 and other documents subsequently filed with or furnished to the U.S. Securities and Exchange Commission. Any forward-looking statement made in this press release speaks only as of the date hereof. Factors or events that could cause ReWalk’s actual results to differ from the statements contained herein may emerge from time to time, and it is not possible for ReWalk to predict all of them. Except as required by law, ReWalk undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.